Search filters

List of works by Dan G Duda

A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients

scientific article

Combining microenvironment normalization strategies to improve cancer immunotherapy

scientific article published on 03 February 2020

Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy

scientific article published on 09 February 2022

Discoveries: an innovative platform for publishing cutting-edge research discoveries in medicine, biology and chemistry

scientific article published on 31 December 2013

Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma

scientific article published on 14 October 2019

FATTY ACID SYNTHESIS IS REQUIRED FOR BREAST CANCER BRAIN METASTASIS

scientific article published on 01 April 2021

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

scientific article published on 24 March 2021

Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2.

scientific article published in March 2018

Phase 1 and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer

scientific article published on 02 September 2020

Phase I and biomarker study of plerixafor and bevacizumab in recurrent high-grade glioma.

scientific article

Phase II trial of ponatinib in patients with bevacizumab-refractory glioblastoma

scientific article published on 24 August 2019

Randomized phase II and biomarker study of pembrolizumab plus bevacizumab versus pembrolizumab alone for recurrent glioblastoma patients

scientific article published on 16 November 2020

Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma

scientific article published on 01 November 2020

Role of Apelin in Glioblastoma Vascularization and Invasion after Anti-VEGF Therapy: What Is the Impact on the Immune System?

scientific article published on 01 May 2019

Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition

scientific article published on 01 December 2019

The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation

scientific article published on May 2017